Abstract
Intractable ventricular tachyarrhythmia associated with hypomagnesemia responds well to magnesium given intravenously. Two patients with recurrent ventricular tachycardia and ventricular fibrillation associated with normal serum magnesium levels and resistant to treatment with potassium chloride, lidocaine and bretylium tosylate responded dramatically to the administration of magnesium sulfate. A third patient in whom the serum magnesium level was unknown also showed dramatic response to magnesium therapy.
Magnesium depletion probably interferes with sodium-potassium adenosine triphosphatase enzyme activity and causes ionic imbalance and electrical instability of purkinje's fibers. Without obvious magnesium depletion this element in high concentration may still prolong transient inward current, prolong the effective refractory period, increase the membrane potential and control ventricular tachyarrhythmia.
When ventricular fibrillation or malignant ventricular tachycardia cannot be controlled with lidocaine and other conventional drugs, we recommend infusing magnesium sulfate, 2 to 3 grams in one minute, followed by 10 grams over five hours.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dyckner T., Wester P. O. Relation between potassium, magnesium and cardiac arrhythmias. Acta Med Scand Suppl. 1981;647:163–169. doi: 10.1111/j.0954-6820.1981.tb02652.x. [DOI] [PubMed] [Google Scholar]
- ENSELBERG C. D., SIMMONS H. G., MINTZ A. A. The effects of magnesium upon cardiac arrhythmias. Am Heart J. 1950 May;39(5):703–712. doi: 10.1016/0002-8703(50)90130-x. [DOI] [PubMed] [Google Scholar]
- Horowitz L. N., Greenspan A. M., Spielman S. R., Josephson M. E. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Circulation. 1981 May;63(5):1120–1128. doi: 10.1161/01.cir.63.5.1120. [DOI] [PubMed] [Google Scholar]
- Iseri L. T., Freed J., Bures A. R. Magnesium deficiency and cardiac disorders. Am J Med. 1975 Jun;58(6):837–846. doi: 10.1016/0002-9343(75)90640-3. [DOI] [PubMed] [Google Scholar]
- Jenzer H. R., Hagemeijer F. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations. Eur J Cardiol. 1976 Dec;4(4):447–451. [PubMed] [Google Scholar]
- Kass R. S., Lederer W. J., Tsien R. W., Weingart R. Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Purkinje fibres. J Physiol. 1978 Aug;281:187–208. doi: 10.1113/jphysiol.1978.sp012416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pamintuan J. C., Dreifus L. S., Watanabe Y. Comparative mechanisms of antiarrhythmic agents. Am J Cardiol. 1970 Nov;26(5):512–519. doi: 10.1016/0002-9149(70)90709-5. [DOI] [PubMed] [Google Scholar]
- Smith W. M., Gallagher J. J. "Les torsades de pointes": an unusual ventricular arrhythmia. Ann Intern Med. 1980 Oct;93(4):578–584. doi: 10.7326/0003-4819-93-4-578. [DOI] [PubMed] [Google Scholar]
- Wacker W. E. The biochemistry of magnesium. Ann N Y Acad Sci. 1969 Aug 15;162(2):717–726. doi: 10.1111/j.1749-6632.1969.tb13003.x. [DOI] [PubMed] [Google Scholar]
- Wester P. O., Dyckner T. Diuretic treatment and magnesium losses. Acta Med Scand Suppl. 1981;647:145–152. doi: 10.1111/j.0954-6820.1981.tb02650.x. [DOI] [PubMed] [Google Scholar]
- Whang R., Aikawa J. K. Magnesium deficiency and refractioriness to potassium repletion. J Chronic Dis. 1977 Feb;30(2):65–68. doi: 10.1016/0021-9681(77)90075-3. [DOI] [PubMed] [Google Scholar]
- Whang R., Oei T. O., Aikawa J. K., Ryan M. P., Watanabe A., Chrysant S. G., Fryer A. Magnesium and potassium interrelationships, experimental and clinical. Acta Med Scand Suppl. 1981;647:139–144. doi: 10.1111/j.0954-6820.1981.tb02649.x. [DOI] [PubMed] [Google Scholar]